Suchergebnisse - "Lolli, Cristian"

PubPharm (114)

1

External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations

enthalten in: Clinical & experimental metastasis | 2024

von Maffezzoli, M. | Santoni, M. | Mazzaschi, G. | +24

2

Papillary Renal Cell Carcinoma : Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 Study

enthalten in: European urology oncology | 2024

von Massari, F. | Mollica, V. | Fiala, O. | +21

3

Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer : Results from the Meet-URO 10 Study

enthalten in: European urology open science | 2024

von Casadei, C. | Scarpi, E. | Conteduca, V. | +18

4

External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations

enthalten in: Clinical & experimental metastasis | 2024

von Maffezzoli, M. | Santoni, M. | Mazzaschi, G. | +24

5

Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer care

enthalten in: Prostate cancer and prostatic diseases | 2024

von Conteduca, V. | Di Tullio, P. | Allamprese, R. | +21

6

The New Frontier of Immunotherapy : Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer

enthalten in: Cancers | 2023

von Schepisi, G. | Gianni, C. | Palleschi, M. | +6

7

Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy : The Meet-URO12 Randomized Phase 2 Trial

enthalten in: European urology | 2023

von Vignani, F. | Tambaro, R. | De Giorgi, U. | +22

8

Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients

enthalten in: Frontiers in oncology | 2023

von Farolfi, A. | Petracci, E. | Gurioli, G. | +13

9

Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy : Potential treatment options against Testicular Germ Cell Tumors

enthalten in: Frontiers in immunology | 2023

von Schepisi, G. | Gianni, C. | Cursano, M. | +8

10

Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide

enthalten in: Cancers | 2022

von Conteduca, V. | Casadei, C. | Scarpi, E. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]